ScanNanoTreat Kicks Off in Paris – A Major Step Forward for European Cancer Innovation
This week marked an exciting milestone for European cancer innovation as the ScanNanoTreat project officially launched at a two-day kick-off meeting hosted by Guerbet at their global headquarters in Paris on 3–4 June 2025.
Funded by the European Innovation Council (EIC) Transition programme, ScanNanoTreat brings together leading academic and industrial partners across Europe to deliver a radically new approach to diagnosing and treating solid tumours.
The kick-off meeting aligned the team on scientific priorities, governance, technical roadmap, and commercial exploitation strategy. The atmosphere across both days was highly collaborative and energising, a promising start for such an ambitious initiative.
